Fluoromount-G® Anti-Fade

Cat. No.
0100-35  
Size
20 mL  
Price (USD)
$75.00 
Description Fluoromount-G® Anti-Fade is an aqueous-based compound for mounting slides used in microscopy applications in which the preservation of fluorescence intensity is critical. This mounting medium provides a semi-permanent seal for storage of slide preparations and since Fluoromount-G® Anti-Fade is water-soluble, the coverslip may be removed by submerging the slide in a PBS solution until the coverslip is loosened.
Buffer Formulation Glycerol containing anti-fade components and other proprietary ingredients
Volume 20.0 mL
Storage & Handling Store at 2-8°C
Please refer to product specific SDS
Applications Immunohistochemistry-Frozen Sections
Immunohistochemistry-Paraffin Sections
Immunocytochemistry
Recommended Dilutions Please refer to product specific Technical Bulletin
  • Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY2 (SB Cat. No. 7100-21), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3 (SB Cat. No. 7100-12).
  • Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with DAPI.
  • Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF488 (SB Cat. No. 1030-30).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TXRD (SB Cat. No. 7100-07), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TRITC (SB Cat. No. 1030-03).
  • Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3.5 (SB Cat. No. 7100-24).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TXRD (SB Cat. No. 1030-07).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TRITC (SB Cat. No. 7100-03), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF555 (SB Cat. No. 1030-32).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
  • Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-FITC (SB Cat. No. 1030-02).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY2 (SB Cat. No. 7100-21), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3 (SB Cat. No. 7100-12).
 

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with DAPI.
 

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF488 (SB Cat. No. 1030-30).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TXRD (SB Cat. No. 7100-07), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TRITC (SB Cat. No. 1030-03).
 

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3.5 (SB Cat. No. 7100-24).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TXRD (SB Cat. No. 1030-07).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TRITC (SB Cat. No. 7100-03), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF555 (SB Cat. No. 1030-32).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).
 

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-FITC (SB Cat. No. 1030-02).
 
Related Products (6)
Fluoromount-G® is a registered trademark of Southern Biotechnology Associates, Inc.
Alexa Fluor® and Texas Red® are registered trademarks of Thermo Fisher Scientific, Inc. and its subsidiaries
Cy® is a registered trademark of GE Healthcare.